Tubeless Intersegmentectomy Plane Identification With Fluorography

Tubeless Intersegmentectomy Plane Identification With Inflation- Deflation Line Combined With Fluorography

Status

Recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05479825

Enrollment

Registered

2022-07-29

Start date

2022-01-01

Completion date

2028-12-31

Last updated

2022-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Operation Time, Postoperative Complications

Brief summary

Background: We aimed to evaluate the combination of inflation- deflation method and fluorography with the ICG injection in the tubeless minimally invasive segmentectomy (no intubation, VATS or Robotic). Methods: A one- armed, prospective randomized controlled study was designed. The intersegmental plane was not so clear during the tubeless minimally invasive segmentectomy, and the presentation of the plane sometimes cost more time. This study will evaluate consecutive patients with the combination of inflation- deflation method and fluorography with the ICG injection.

Interventions

PROCEDUREinflation- deflation line combined with ICG fluorography

Identification of the intersegmental plane using inflation- deflation line combined with ICG fluorography under the status of tubeless

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

1. cardio- pulmonary function can tolerate the minimally invasive surgery (including VATS and robotic surgery); 2. benign pulmonary lesion considering for segmentectomy; 3. ≤2cm pulmonary adenocarcinoma with ground- glass components, considering for segmentectomy.

Exclusion criteria

1. cardio- pulmonary function can not tolerate the minimally invasive surgery (including VATS and robotic surgery); 2. segmentectomy is not considered as the surgery plan.

Design outcomes

Primary

Measure	Time frame	Description
time of description and management of the intersegmental plane	during surgery	time of description and management of the intersegmental plane
perioperative complication rate	within 7 days after surgery	perioperative complication rate
incisal margin of the tumor	during surgery	incisal margin of the tumor

Secondary

Measure	Time frame	Description
disease- free survival	within 5 years after surgery	DFS

Countries

China

Contacts

Primary ContactYunpeng Zhao, doctor

zyp_baggio@163.com18766188692

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026